Design Therapeutics (DSGN) Free Cash Flow (2020 - 2021)

Historic Free Cash Flow for Design Therapeutics (DSGN) over the last 2 years, with Q4 2021 value amounting to -$9.6 million.

  • Design Therapeutics' Free Cash Flow fell 23523.44% to -$9.6 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$30.9 million, marking a year-over-year decrease of 25604.05%. This contributed to the annual value of -$43.4 million for FY2024, which is 2613.4% up from last year.
  • Design Therapeutics' Free Cash Flow amounted to -$9.6 million in Q4 2021, which was down 23523.44% from -$9.1 million recorded in Q3 2021.
  • Design Therapeutics' Free Cash Flow's 5-year high stood at -$1.3 million during Q2 2020, with a 5-year trough of -$9.6 million in Q4 2021.